b-Oxidative enzymes for fatty acid degradation (Fad) of long-chain fatty acids (LCFAs) are induced in vivo during lung infection in cystic fibrosis patients, and this may contribute to nutrient acquisition and pathogenesis of Pseudomonas aeruginosa. The promoter region of one P. aeruginosa b-oxidation operon, fadBA5 (PA3014 and PA3013), was mapped. Focusing on the transposon mutagenesis of strain PAO1 carrying the P fadBA5 -lacZ fusion, a regulator for the fadBA5 operon was identified to be PsrA (PA3006). Transcriptome analysis of the DpsrA mutant indicated its importance in regulating b-oxidative enzymes. These microarray data were confirmed by real-time RT-PCR analyses of the fadB5 and lipA (encoding a lipase) genes. Induction of the fadBA5 operon was demonstrated to respond to novel LCFA signals, and this induction required the presence of PsrA, suggesting that LCFAs bind to PsrA to derepress fadBA5. Electrophoretic mobility shift assays indicate specific binding of PsrA to the fadBA5 promoter region. This binding is disrupted by specific LCFAs (C 18 : 1 D9
INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen, and the spectrum of infections and diseases it causes is second to none. P. aeruginosa can cause infections of the ear, bone, joint, skin and soft tissue, and more serious infections, including meningitis, bacteraemia, endocarditis, ocular infections, hospital-acquired pneumonia, and lung infections in cystic fibrosis (CF) patients (Baltch & Griffin, 1977; Bowton, 1999; Fleiszig et al., 1995; Greenberger, 1997; Lode et al., 2000; Pruitt et al., 1998; Reyes & Lerner, 1983; Richards et al., 1999; Schaberg et al., 1991) . P. aeruginosa lung infections transpire in nosocomial pneumonia and in CF patients. Nosocomial pneumonia is the second most common of all nosocomial infections, and P. aeruginosa has been the most frequently isolated microbe responsible (Pennington, 1994; Richards et al., 1999) . In addition, over 93 % of CF patients between the ages of 18 and 24 have been infected with P. aeruginosa (Doring, 1997) .
Fatty acid degradation (Fad) pathways may play critical roles in P. aeruginosa pathogenesis. It has recently been demonstrated that the Fad pathways of P. aeruginosa may have important implications in nutrient acquisition and pathogenesis within the CF lung (Son et al., 2007) , through the degradation of an essential lung surfactant component phosphatidylcholine (PC). The degradation of one PC component, long-chain fatty acid (LCFA), potentially occurs through three different b-oxidation pathways, involving three fadBA operons (fadAB1, PA1737 and PA1736; fadAB4, PA4786 and PA4785; and fadBA5, PA3014 and PA3013) (Son et al., 2007 (Son et al., , 2008 unpublished data) . Thus, understanding the genetic regulation of Fad could have direct relevance to the physiology and pathogenesis of this micro-organism within the context of CF infections. The aerobic Fad pathway in Escherichia coli is well established, and several of the genes are negatively regulated by FadR in the absence of external fatty acids (FAs) ¢C12 (Cronan & Satyanarayana, 1998; DiRusso et al., 1992) , including fadA, fadB, fadD, fadE and fadL (Campbell & Cronan, 2002) . The fad genes are derepressed by acyl-CoA (.C10) binding to FadR, and this complex no longer activates fab genes (DiRusso et al., 1992; Henry & Cronan, 1992) . However, the regulation of Fad in P. aeruginosa has not been characterized, and deciphering the regulation mechanism of Fad is important to further understand the physiology and pathogenesis of P. aeruginosa.
In this study, we focused on identifying the regulation mechanism of the P. aeruginosa fadBA5 operon, which is involved in Fad. We performed transposon mutagenesis to identify a regulator of the fadBA5 operon. We showed that this regulator, PsrA (PA3006), represses the fadBA5 operon. This repression is relieved by LCFA signals, as shown by gene fusion data, and this was consistent with our in vitro DNA binding results. We performed microarray experiments to further identify other genes within the regulon controlled by this regulatory protein. The microarray data were confirmed by real-time RT-PCR for fadB5 and lipA.
METHODS
Bacterial strains, media, and culture conditions. E. coli HPS1 (Schweizer, 1994) was routinely used as a strain for cloning and was cultured in Luria-Bertani (LB) medium (Difco). P. aeruginosa strain PAO1 (Holloway et al., 1994; Stover et al., 2000) and derivatives were cultured on Pseudomonas Isolation Agar (PIA; Difco) or LB medium. All chemicals were purchased from Sigma. FA (butyric acid, C 4 : 0 ; Ncaproic acid, C 6 : 0 ; caprylic acid, C 8 : 0 ; capric acid, C 10 : 0 ; lauric acid, C 12 : 0 ; myristic acid, C 14 : 0 ; palmitic acid, C 16 : 0 and oleic acid, C 18 : 1 D9 ) stock solutions at 3 % (w/v) were made with equimolar KOH and 1 % Brij-58 [poly(oxyethylene) cetyl ether]. Growth curves ( Fig. 1) were performed in 16 M9 (containing 0.5 mM MgCl 2 and 0.02 mM CaCl 2 )+1 % Brij-58 supplemented with 20 mM glucose or 0.2 % of different FAs as sole carbon source. Growth curves for b-galactosidase activity (Fig. 3) were performed in 16 M9+1 % Brij-58+40 mM glucose with or without 0.1 % of the particular FA. Complementation of the psrA mutation ( Fig. 5b ) was performed in LB+1 % Brij-58 with or without 0.2 % C 18 : 1 D9 . Unless indicated otherwise, the cultures were grown at 37 uC with a shaking speed of 250 r.p.m.
Molecular methods and reagents. Restriction enzymes, dNTPs, T4 DNA polymerase and ligase were purchased from New England Biolabs and used as recommended by the supplier. Plasmids and DNA gel bands were isolated using the Zyppy Plasmid Miniprep Kit I and Zymoclean Gel DNA Recovery kit, respectively, from Zymo Research Corporation. Chromosomal DNA was isolated with the IsoQuick nucleic acid extraction kit (Orca Research). E. coli competent cell preparations, blunt-ending of DNA fragments with T4 DNA polymerase, and other molecular techniques were performed according to Sambrook & Russell (2001) . Oligonucleotide primers (Table 1) were synthesized by Integrated DNA Technologies (IDT). Southern hybridization analysis was performed as described previously (Hoang et al., 1998) . P. aeruginosa competent cells were prepared as described elsewhere (Choi et al., 2006) . Generally, we performed the various PCRs by initial denaturation for 1 min at 94 uC and 34 cycles of 45 s at 94 uC, 30 s at 58 uC, and 1 min kb 21 at 72 uC, and a final step of 10 min at 72 uC was included. Pfu was purchased from Stratagene.
Characterization of the PAO1-DfadBA5 mutant strain and complementation study. The PAO1 DfadBA5 mutant strain, PAO1-DfadBA5, has been described previously (Son et al., 2007) . Complementation of the PAO1-DfadBA5 mutant was done as follows. The fadBA5 operon, including its native promoter region, was amplified from the PAO1 chromosome by PCR using oligos #287 and # 273. The PCR product was digested with EcoRI and cloned into mini-CTX2 (Hoang et al., 2000) digested with SmaI+EcoRI, yielding mini-CTX2-fadBA5. Next, mini-CTX2-fadBA5 was transformed into the PAO1-DfadBA5 mutant to integrate into its chromosome and complement the DfadBA5 mutation.
Growth curve studies were performed on three strains (PAO1, PAO1-DfadBA5 and PAO1-DfadBA5/miniCTX2-fadBA5). These strains were grown overnight at 37 uC in PIA medium. Overnight cultures were washed twice with one volume of 16 M9 buffer and resuspended in an equal volume of the same buffer. Resuspended cultures were then diluted 100-fold into fresh 16 M9+20 mM glucose or 0.2 % of a FA (C 4 : 0 , C 6 : 0 , C 8 : 0 , C 10 : 0 , C 12 : 0 , C 14 : 0 , C 16 : 0 or C 18 : 1 D9 ). Growth was then initiated. At each time point, aliquots of each culture were diluted fourfold in 4 % Brij-58 and OD 540 measurements were taken.
Promoter mapping. We mapped transcript start sites for fadB5 (PA3014), according to a method for mapping eukaryotic transcript start sites described elsewhere (Tabansky & Nurminsky, 2003) . Cells, grown in 16 M9+palmitate, were harvested for promoter mapping in exponential phase (OD 540~0 .6), early stationary phase (10 h after exponential phase), and late stationary phase (18 h after early stationary phase). All reagents required for transcriptional start-site mapping were supplied in the SMART RACE cDNA Amplification kit (Clontech, BD Biosciences). Briefly, total mRNA was isolated with an on-column DNase I treatment, using the Qiagen RNeasy mini kit. A 1 mg sample of total mRNA was assembled with a SMART primer and the first gene-specific primer (primers #244 and #279, Table 1); each primer was at 2 mM final concentration. cDNA synthesis was carried out with the reagents supplied and as recommended by the manufacturer. The diluted cDNA was used as a template in a PCR with a second nested gene-specific primer (Table 1 , primer #280) and the SMART RACE primer. PCR products were purified from gel slices and sequenced with a third nested gene-specific primer (Table 1, primer #281) at our local core facility. P fadBA5 -lacZ fusion construction and b-galactosidase assay.
The P fadBA5 -lacZ transcriptional fusion was constructed by amplifying the fadBA5 promoter region, encompassing nucleotides 148-266 upstream of the start codon. PCR was performed using primers #287 and #289 with PAO1 chromosomal DNA. The resulting 120 bp fragment was cut with HindIII and cloned into HindIII-and SmaIdigested pTZ120 (a derivative of pTZ110) (Schweizer & Chuanshuen, 2001 ) to yield pTZ120-P fabAB . For integration into the P. aeruginosa genome, the P fadBA5 -lacZ fusion was removed by AflIII digestion, blunt-ended, and then digested with HindIII. This fragment was then subcloned between the HindIII and SmaI sites of mini-CTX2 to yield mini-CTX2-P fadBA5 -lacZ. Chromosomal integration of this mini-CTX2-lacZ fusion vector in P. aeruginosa, excision of unwanted plasmid sequences and verification of insertion at the chromosomal attB locus were performed as described previously (Hoang et al., 2000) .
b-Galactosidase activities were measured for the integrated P fadBA5 -lacZ fusion under various growth conditions. Cells harbouring the fusions were grown overnight in PIA medium. Overnight cultures were washed twice with one volume of 16 M9 buffer and resuspended in an equal volume of the same buffer. Resuspended cultures were then diluted 100-fold into fresh 16 M9+40 mM glucose±0.1 % FA (C 4 : 0 , C 6 : 0 , C 8 : 0 , C 10 : 0 , C 12 : 0 , C 14 : 0 , C 16 : 0 or C 18 : 1 D9 ). Growth curves were determined for each culture by diluting them fourfold in 4 % Brij-58, after which OD 540 was measured. All growth curves had identical growth rates (data not shown). Cell cultures (1 ml) were taken at mid-exponential phase (OD 540~1 .4) during the growth curve experiments, and b-galactosidase assays were performed from the same cultures. b-Galactosidase assays were done in triplicate and measured in Miller units (Miller, 1992; mean±SEM) .
Identification and characterization of transposon mutants affecting fadBA5 expression. The fusion strain PAO1-P fadBA5 -lacZ was subjected to transposon mutagenesis using the mariner transposon vector pBT20. The transposon in pBT20 was conjugally transferred by biparental mating into PAO1-P fadBA5 -lacZ, following a protocol described elsewhere (Kulasekara et al., 2005) . Mating mixtures were scraped and resuspended in 3 ml LB. Then, 300 ml of this suspension was plated onto PIA+gentamicin (Gm) at 150 mg ml 21 +X-Gal (40 mg ml 21 ) and incubated at 37 uC. Colonies that appeared more blue were selected. Transposon insertion sites were determined through sequencing the flanking region of the transposon by a semi-random PCR method, as described elsewhere (LevanoGarcia et al., 2005) , using random primer # 524 and transposonspecific primer #463, followed by the nested primers #525 and #526 (Table 1) . b-Galactosidase activities were measured and compared with those of the parental strain (PAO1-P fadBA5 -lacZ) for the three mutants identified as regulatory mutants ( Supplementary Fig. S1 ), where all were grown in LB.
Transduction and complementation of the PAO1-P fadBA5 -lacZ/ psrA : : Tn-Gm r mutant. The chromosomal disrupted psrA : : Tn-Gm r mutation was transduced back into the original parental PAO1-P fadBA5 -lacZ fusion strain following a protocol described elsewhere The growth rates and overall cell densities were identical between the wild-type PAO1 strain and the fadBA5-complemented strain. The PAO1-DfadBA5 mutant grew similarly to the wild-type on glucose and C 4 : 0 to C 10 : 0 . However, compared with PAO1, the PAO1-DfadBA5 mutant showed growth defects (slower growth and lower final cell densities) when grown on C 12 : 0 to (Choi et al., 2006) . Transposon mutants harbouring the P fadB5 -lacZ reporter gene fusions and four independent isolates of the retransduced PAO1-psrA : : Tn-Gm r mutants were grown overnight in PIA+Gm (150 mg ml
21
), along with PAO1-P fadBA5 -lacZ in PIA. Overnight cultures were washed twice and resuspended in an equal volume of LB medium. Resuspended cultures were then diluted 100-fold into fresh LB. Growth curves were performed, and bgalactosidase assays at mid-exponential phase were carried out for each strain.
For the complementation study, the coding region of psrA was amplified from PAO1 chromosomal DNA using oligonucleotides # 691 and # 692. The NdeI/BamHI-digested PCR product was cloned into pUCP-Nde (Cronin & McIntire, 1999) that had been digested with the same enzymes. Competent cells of the PAO1-P fadBA5 -lacZ/ psrA : : Tn-Gm r mutant were prepared and electroporated with 50 ng plasmid DNA of pUCP-Nde-psrA or pUCP-Nde, as described elsewhere (Choi et al., 2006) , and selected on PIA+carbenicillin (Cb;500 mg ml 21 ). Transposon mutants with the P fadBA5 -lacZ reporter gene fusion, harbouring pUCP-Nde-psrA or pUCP-Nde, were grown overnight in PIA+Cb500, washed twice with LB, and diluted 100-fold into fresh LB+Cb500+1 % Brij-58 with or without 0.2 % C 18 : 1 D9 . Growth curves were performed and b-galactosidase assays at mid-exponential phase were carried out for each strain.
Purification of His 6 -PsrA. His 6 -PsrA was expressed and purified using the E. coli T7 RNA polymerase expression system. The expression vector pET15b-psrA was constructed by cloning the psrA-encoding region from pUCP-Nde-psrA into pET15b as an NdeI-BamHI fragment, and then transformed into the BL21-Codonplus(DE3)-RIPL strain (Stratagene). The transformed BL21-Codonplus(DE3)-RIPL strain containing pET15b-psrA was grown and PsrA was expressed as described previously (Hoang et al., 2002) . After expression, cells were harvested and protein purification was performed as described previously (Hoang et al., 2002) . Protein concentration was determined by Bradford Assay (Bio-Rad), using BSA as a standard, prior to electrophoretic mobility shift assay (EMSA) studies.
EMSA of PsrA binding to P fadBA5 . Purified His 6 -PsrA was incubated with the P fadBA5 promoter DNA fragment (amplified with oligonucleotides #287 and #289), and a gel mobility shift was performed to demonstrate specific DNA binding. Essentially, 100 ng purified P fadBA5 DNA fragment was incubated with 1 mg of purified His 6 -PsrA in 16 binding buffer [20 mM HEPES, pH 7.6, 1 mM EDTA, 10 mM (NH 4 ) 2 SO 4 , 1 mM DTT, 1 % (w/v) Tween 20, 150 mM KCl] with 1 mg poly(dI-C) and 0.1 mg poly-L-lysine for 30 min at room temperature. For all the FAs used in EMSA (C 18 : 1 D9 , C 16 : 0 , C 14 : 0 , C 12 : 0 , C 10 : 0 , C 8 : 0 , C 6 : 0 and C 4 : 0 ), 1 mM stocks were made by dissolving the FA in 0.2 % Brij-58 with equimolar KOH. Oleoyl-CoA was diluted to 1 mM with 16 binding buffer+0.2 % Brij-58. Master-mix containing binding buffer, poly(dI-C), poly-Llysine, and the DNA fragment of P fadBA5 was made for each gel, then FAs (2.5-50 mM) or oleoyl-CoA (50 mM) were added to each aliquot to the appropriate concentration. Purified His 6 -PsrA was always the last component to be added to the binding reactions. Each binding reaction was loaded on an 8 % native polyacrylamide gel (pre-run at 90 V for 1 h) and ran for 120 min at 90 V. Gels were stained with SYBR Green as recommended by the manufacturer of EMSA kit E33075 (Invitrogen/Molecular Probes).
RNA isolation, cDNA synthesis and labelling, and Affymetrix GeneChip processing. Starter cultures of PAO1 or the PAO1-psrA : : Tn-Gm r mutant derivative were grown in LB for 14 h at 37 uC with aeration, and a 1 : 100 dilution of the starter cultures was inoculated into 20 ml LB in a 125 ml flask. Cultures were then incubated at 37 uC with shaking and grown up to mid-exponential phase (OD 540~0 .6). Cells were then harvested and P. aeruginosa mRNA isolated. cDNA syntheses and labelling, as well as GeneChip processing and microarray analysis, were performed as described previously (Son et al., 2007) . Analysis was done by conducting pair-wise comparisons between two replicates of PAO1 and three replicates of PAO1-psrA : : Tn-Gm r grown in LB. Genes that exhibited a twofold or greater increase in expression in PAO1-psrA : : Tn-Gm r relative to PAO1 form one list (PsrA-repressed genes; Table 2 ), while genes that showed a twofold or greater increase in expression in PAO1 compared with PAO1-psrA : : Tn-Gm r form another (PsrA-activated genes; Table 3 ).
Gene assignment. Gene assignment was assisted for some genes using COG predictions in the Pseudomonas Genome Database (http://www.pseudomonas.com/index.jsp).
Real-time TaqMan RT-PCR and data analysis. Primers, probes and real-time RT-PCR were exactly the same as described previously (Son et al., 2007) . RNAs used were from the same preparation as described above for microarray experiments. Because normalization by geometric averaging using multiple housekeeping genes has been shown to yield more accurate fold-changes than using a single housekeeping gene (Vandesompele et al., 2002) , we opted to use three housekeeping genes for our normalizations. Three housekeeping genes described previously (PA1769, PA1795 and PA1805; Son et al., 2007) were selected and utilized to normalize fold-changes for lipA and fadB5 in the PAO1-psrA : : Tn-Gm r mutant compared with PAO1.
RESULTS AND DISCUSSION
FadB5 and FadA5 are involved in LCFA utilization P. aeruginosa has a large array of b-oxidation enzymes (Stover et al., 2000) , and the organism is capable of degrading short-, medium-and long-chain fatty acids (SCFAs, MCFAs and LCFAs) as sole carbon sources. Among FadB and FadA proteins in P. aeruginosa, FadB5 (PA3014) and FadA5 (PA3013) have the highest homology to their E. coli counterparts (Campbell & Cronan, 2002; Yang et al., 1991) , with similarities of 72 % (54 % identity) and 76 % (61 % identity), respectively. Initial characterization demonstrated that the fadBA5 operon is involved in LCFA utilization (Son et al., 2007) . In our previous study, fadBA5 was not fully characterized with respect to the utilization of FA of different chain lengths as sole carbon sources. In this study, the PAO1-DfadBA5 mutant was further characterized. The PAO1-DfadBA5 mutant had no growth defect when grown on glucose SCFA or MCFA (C 4 : 0 to C 10 : 0 ) as sole carbon source, but it showed defects in growth using LCFAs as sole carbon source (C 12 : 0 , C 14 : 0 , C 16 : 0 and C 18 : 1
D9
, Fig. 1 ). The slower growth and lower cell density of the mutant compared with the wild-type suggest a defect in the ability to degrade these LCFAs and the accumulation of growth-inhibitory intermediates. When the fadBA5 operon was cloned into mini-CTX2 and integrated as a single copy into the PAO1-DfadBA5 mutant background, it completely complemented this mutation (Fig. 1) , indicating that there were no other spurious mutations on the chromosome of the mutant strain other than DfadBA5. There was an incomplete lack of growth using LCFAs as a carbon source for this mutant, because P. aeruginosa has two other fadAB operons [fadAB1 (PA1737 and PA1736; Son et al., 2008) and fadAB4 (PA4786 and PA4785; unpublished data)], which have overlapping functions with fadBA5 for MCFAs and LCFAs.
Although the functions of fadAB4 have yet to be fully characterized, we have recently shown that the fadAB1 operon is induced by MCFAs and to a lesser extent by LCFAs (Son et al., 2008) , perhaps for the degradation of these carbon sources, suggesting that FadBA1 has overlapping functions with FadBA5 in the metabolism of different FA chain lengths. We have shown here that fadBA5 is important for growth on LCFAs in vitro. In vivo during lung infection, fadBA5 was significantly induced, suggesting that LCFAs are also available in vivo as a source of nutrients (Son et al., 2007) . However, the regulation of this operon is undefined and poorly understood in P. aeruginosa.
Regulatory region of fadBA5
Based on an established non-radioactive method for mapping transcriptional start sites (Tabansky & Nurminsky, 2003) , we mapped the promoter of the fadBA5 operon. Our data shown in Fig. 1 indicate induction of fadBA5 by palmitate (C 16 : 0 ). Therefore, to map the fadBA5 transcript start site, we utilized RNA isolated from PAO1 grown in 16 M9 minimal media containing palmitic acid as the sole carbon source to induce the expression of these fad genes. We mapped the transcript start site for fadBA5 to 185 bp upstream of the start codon of fadB5 (Fig. 2a, c) . We utilized free software (http://nostradamus.cs.rhul.ac.uk/~leo/sak_demo/) for the prediction of prokaryotic s 70 promoters using sequence alignment kernel methods (Gordon et al., 2003) , which predicted a perfect match to our fadBA5 transcriptional start-site mapping data. This gives further confirmation of the promoter mapping method. There is a pseudopalindromic sequence, with one base mismatch, at the 210 and 235 region of this mapped s 70 promoter (blue arrows in Fig. 2a ). Since the mapping method is based on RT-PCR and is semiquantitative, the band in Fig. 2 (b) (lane 1) indicated the expression of fadBA5 in the exponential phase during active degradation of palmitate as the sole carbon source, and the expression of fadBA5 was not detected in early or late stationary phase (Fig. 2b) .
LCFAs induce fadBA5
Since we had shown that the fadBA5 operon is required for growth on LCFAs (Fig. 1) and we had mapped the promoter of fadBA5 (Fig. 2) , we next wanted to determine which FA chain lengths induce fadBA5. A P fadBA5 -lacZ fusion was constructed in mini-CTX2 and introduced as a stable single copy into the P. aeruginosa chromosome to study the regulation of fadBA5 by LCFAs. We analysed the expression of the P fadBA5 -lacZ fusion in strain PAO1 grown in 16 M9 glucose media±FA of different chain lengths. As shown in Fig. 3, fadBA5 was tightly repressed when grown with glucose as the sole carbon source at midexponential phase. This operon was also repressed in the presence of FA from C 4 : 0 to C 10 : 0 at mid-exponential phase. However, at mid-exponential phase, fadBA5 was ) and to a lesser extent by C 12 : 0 (Fig. 3) . We had determined that at 40 mM glucose in all media with and without FA, the growth rates for the fusion strain were identical throughout the exponential phase for all cultures (data not shown). Therefore, the induction of the fadBA5 operon by LCFAs at mid-exponential phase was not due to differences in growth rates. This induction of fadBA5 by LCFAs (Fig. 3 ) also correlates well with its metabolic function and with its growth on similar FA chain lengths (Fig. 1) .
Identification of PsrA (PA3006) as the fadBA5 regulator
To initiate studies on the fadBA5 regulation mechanism, we searched for a regulator of fadBA5. We utilized a transposon mutagenesis approach similar to that described elsewhere, using the gentamicin-resistant (Gm r ) transposon vector pBT20 (Kulasekara et al., 2005) to randomly mutagenize the chromosome of strain PAO1 carrying a P fadBA5 -lacZ fusion. Since it is our hypothesis that there is a repressor that regulates fadBA5, we looked for Gm rtransposon mutants of PAO1-P fadBA5 -lacZ that were bluer on X-Gal-containing media, signifying transposon inactivation of a potential negative regulator. We sequenced 67 bluer transposon mutants as described elsewhere (LevanoGarcia et al., 2005) (Supplementary Table S1 ) to identify the inactivation of any potential regulator, and this is summarized in Fig. 4 . It is interesting to see that a large number of bluer colonies affecting fadBA5 expression were associated with LPS biosynthesis (wpb genes), suggesting a possible connection between Fad and LPS biosynthesis. However, further research is required to determine the connection between Fad and LPS biosynthesis. Of interest were three probable transcriptional regulators (PA2601, PA3006 or PsrA, and PA3508; Supplementary Table S1). More thorough measurements of b-galactosidase activities of these three regulatory mutants showed increased bgalactosidase activities (. twofold) for the PA2601 : : TnGm r and psrA : : Tn-Gm r mutants, which significantly affected the expression of fadBA5 during exponential phase ( Supplementary Fig. S1 ). Southern hybridization analysis indicated that there were two transposons in strain PAO1-P fadBA5 -lacZ/PA2601 : : Tn-Gm r and a single transposon in the chromosome of strain PAO1-P fadBA5 -lacZ/psrA : : TnGm r ( Supplementary Fig. S1 ). We separated and sequenced the other mutation in the strain carrying the PA2601 : : TnGm r mutation, and this indicated that there was another transposon mutation in the LPS biosynthetic gene, wbpM. Separating these two mutations by retransduction of chromosomal fragments (Choi et al., 2006) into the PAO1-P fadBA5 -lacZ fusion strain indicated that PA2601 does not affect the expression of fadBA5 (data not shown), and that the increased P fadBA5 promoter activity was due to the wbpM mutation. In addition, purified His-tagged PA2601 did not bind to the fadBA5 promoter region (data not shown), showing further that PA2601 was not involved in the regulation of fadBA5.
Constitutive expression of fadBA5 was due to a single psrA : : Tn-Gm r mutation ( Fig. 5 and Supplementary Fig.  S1 ). To rule out potential fadBA5 promoter mutation(s) causing constitutive P fadBA5 -lacZ expression in the psrA : : Tn-Gm r mutant, we transduced this mutation back into the parental PAO1-P fadBA5 -lacZ fusion strain, as described elsewhere (Choi et al., 2006) . Four independent transductants were again measured for the expression of the P fadBA5 -lacZ fusion, and all four mutants showed constitutive expression of fadBA5 (Fig. 5a ), indicating that the derepression of fadBA5 is due to a single mutation in psrA. We further cloned and complemented the psrA : : TnGm r mutation, and the clones complemented the psrA mutation to repress P fadBA5 -lacZ back to wild-type levels (Fig. 5b) . In addition, upon adding oleate (C 18 : 1
D9
) to the LB media, these complemented clones derepressed fadBA5 similarly to wild-type. The vector-alone control showed no repression of fadBA5 (Fig. 5b) , and no further increase in fadBA5 expression was observed upon addition of the FA oleate to the vector-alone control strain. Together, these data for the PAO1-psrA : : Tn-Gm r mutant indicate a requirement for LCFAs to induce the fadBA5 operon in LB media. The growth phase-independent constitutive expression of fadBA5 in the PAO1-P fadBA5 -lacZ/psrA : : TnGm r strain suggests a direct regulatory role of PsrA (PA3006) on fadBA5 (Supplementary Fig. S1a ). We Table S1 . A significant proportion were observed to occur in LPS-related genes.
demonstrate below that PsrA binds directly to the fadBA5 promoter region.
PsrA binds to the promoter region of fadBA5 and is inhibited by LCFAs
To demonstrate direct binding of purified His 6 -PsrA to the promoter region of fadBA5 (P fadBA5 ), we performed in vitro EMSA. The data showed that PsrA binds specifically to P fadBA5 (Fig. 6a, lanes 3 and 4) and that His 6 -PsrA does not bind to other tested promoters or DNA (e.g. the~400 bp aacC1 gentamicin-resistance promoter; data not shown). Since PsrA regulates fadBA5 and fadBA5 is involved in growth on LCFAs, we wanted to see if free LCFAs or longchain acyl-CoAs could inhibit the binding of PsrA to P fadBA5 by acting as an inducer. The LCFA oleate could inhibit PsrA binding. However, oleoyl-CoA, which acts as an inducer of E. coli fad genes by binding to FadR (DiRusso et al., 1992) , could not inhibit PsrA binding to P fadBA5 (Fig.  6a, b) . We next tested the range of FA chain lengths that PsrA could recognize and thereby inhibit the shifting of P fadBA5 . Only LCFAs (C 12 : 0 , C 14 : 0 , C 16 : 0 and C 18 : 1
D9
), but not MCFAs or SCFAs, could visibly inhibit the binding of PsrA to P fadBA5 in vitro (Fig. 6c) . The inhibition of PsrA binding to P fadBA5 DNA was in a gradient fashion from C 12 : 0 to C 14 : 0 and from C 16 : 0 to C 18 : 1 D9 (Fig. 6c) , which is consistent with the induction of P fadBA5 -lacZ by LCFAs (Fig. 3) and the growth characteristics of the DfadBA5 mutant (Fig. 1) . Together, these data, as well as the growth curves and gene fusion experiments (Figs 1 and 3) , consistently indicate that LCFAs are the inducer of fadBA5, and bind to PsrA to derepress the fadBA5 operon in P. aeruginosa.
The protein : DNA and inducer : protein ratios used here are comparable to those of an earlier study (DiRusso et al., 1992) . Since we utilized SYBR Green from an established EMSA kit (E33075, Invitrogen/Molecular Probes) as an alternative to radioactivity for this DNA binding study, a larger amount of DNA (100 ng;~1.28 pmol) was used to visualize the P fadBA5 DNA band rather than that typically used for radioactivity-based EMSA (25 attomol DNA) (DiRusso et al., 1992) . Therefore, the protein (1 mg His 6 -PsrA) to DNA mole ratio was approximately 30 : 1 in our study. This ratio is significantly lower than that in the earlier radioactivity-based study with the E. coli FadR The disrupted PA3006 (PsrA) chromosomal mutation was transduced back into the original parental PAO1-P fadBA5 -lacZ fusion strain. All four retransduced mutants showed deregulation of the P fadBA5 -lacZ fusion similar to the original psrA : : Tn-Gm r mutant, confirming that the derepression of fadBA5 is due to a single mutation in psrA. (b) Complementation of the psrA mutation, in which the coding region of psrA from the initiation codon to the stop codon was cloned into pUCP-Nde and driven by the lac promoter. The pUCP-PA3006 and the pUCP-Nde vector control were transformed into the PAO1-psrA : : Tn-Gm r mutant carrying the chromosomal P fadBA5 -lacZ fusion. When grown in LB, the vector-alone control showed no repression of the P fadBA5 -lacZ fusion in the PAO1-psrA : : Tn-Gm r mutant, whereas three independent pUCP-PA3006 (pUCPNde-psrA) clones showed complementation and repression of this fusion back to wild-type level in LB. As expected, this repression was also relieved by adding FA (oleate, C 18 : 1
) to the LB media. Strains carrying the pUCP control plasmid (in LB and LB+C 18 : 1 D9 ) show that the addition of oleate alone cannot further induce the fadBA5 operon, suggesting that only one pathway, through PsrA, exists to regulate fadBA5. For both (a) and (b), all cultures were grown to mid-exponential phase for bgalactosidase measurements and all cultures had identical growth rates in LB and LB+C 18 : 1
. (DiRusso et al., 1992) , where the protein : DNA mole ratio used was 1000 : 1. Along with the inability of His 6 -PsrA to bind other control DNA (data not shown), this appropriate protein : DNA ratio further supports the hypothesis that the His 6 -PsrA binding to P fadBA5 DNA observed in our study is specific. Given the high concentrations of DNA and His 6 -PsrA used, the 50 mM FA concentration used in this study is reasonable, yielding an inducer (FA) to protein mole ratio of 27 : 1. This value is comparable to that in the earlier E. coli FadR study (DiRusso et al., 1992) , which utilized an inducer (acyl-CoA) to protein mole ratio of 50 : 1. Our data strongly indicate that the binding of His 6 -PsrA to P fadBA5 DNA is specific and is inhibited by LCFAs. The data support the suggestion that the novel signals for PsrA to regulate fadBA5 are LCFAs.
Y. Kang and others

PsrA affects gene expression globally
It has been suggested elsewhere that PsrA, a member of the TetR family of repressors, could affect global gene expression (Kojic et al., 2005; Shen et al., 2006) , including activation of rpoS (Kojic et al., 2002) and the type III secretion system exsCEBA operon (Shen et al., 2006) . A proteomic study has shown that PsrA influences the expression of a few proteins, including FadBA5, but the signal (inducer) and mechanism of regulation by PsrA have not been demonstrated (Kojic et al., 2005) . The full array of genes influenced by PsrA has not been shown. Hence, we wanted to utilize a genomic approach to determine the extent of PsrA-regulated genes, using Affymetrix GeneChips to show differential expression between wildtype PAO1 and the PAO1-psrA : : Tn-Gm r mutant. We grew both strains, with identical growth rates in LB (data not shown), and harvested both strains at the same cell density at mid-exponential phase to determine the difference in gene expression. Table 2 lists genes negatively affected by PsrA. First, PsrA regulates itself, which has been demonstrated elsewhere (Kojic et al., 2002) , and our genomic data indicate a difference of 6.2-fold at midexponential phase. Recently, the expression of psrA and fadBA5 in vivo in the CF lung have also been observed (Son et al., 2007) , suggesting that the bacteria sense free FA in the lung for PsrA to derepress itself and fadBA5. Second, several genes involved in FA metabolism were also negatively regulated by PsrA (Table 2) , including fadBA5 (PA3014 and PA3013) and another possible fad gene, fadE (PA0506). Electron transport genes were significantly induced (PA2951-2953), along with cytochrome P450 (PA3331) ( Table 2 ). This group of genes is significant for Fad, because the result of b-oxidation is the production of reducing power in the form of FADH 2 and NADH. Hence, Fad is closely coupled to electron transport. It has been suggested that the E. coli FadE contains sequences that bind and shuffle its electrons (FADH 2 ) to electron transport protein(s) (Campbell & Cronan, 2002 Pseudomonas fatty acid metabolism regulation
LCFAs (Salaun & Helvig, 1995) , and it exists within the gene cluster for FA catabolism of Pseudonocardia autotrophica that is also regulated by LCFAs (Chen et al., 2005) . It is interesting that we saw a phospholipase D (PA3487) and a lipase (lipA, PA2862) also negatively regulated by PsrA. Of particular significance is the lipase, which could potentially liberate LCFAs from phospholipids (e.g. lung surfactant phosphatidylcholine) (Son et al., 2007) . These LCFAs would then feed directly into b-oxidation through fadBA5. The microarray data were confirmed and were in close agreement with real-time RT-PCR data for both fadB5 and lipA (Table 2 in (Tables 2 and 3) , we focused on genes that potentially contribute to Fad. We found and aligned the consensus sequences upstream of these genes involved in Fad (Fig. 7) , and this suggested a direct regulation mechanism of these genes by PsrA. It is interesting that there are two potential PsrA binding consensus sequences in the fadBA5 promoter region (Figs  2a and 7) . The location of these binding sites relative to the 210 and 235 sequences confirms the role of PsrA as a repressor for the fadBA5 operon (Fig. 2a) . Together with the microarray data and the existence of PsrA binding consensus sequences upstream, several potential fad genes seem to be directly repressed by PsrA, suggesting that one of its major physiological roles is as a regulator of FA metabolism. ), and inhibition by other MCFAs and SCFAs was not detected at this concentration. The amount of P fadBA5 DNA used was 100 ng, and the amount of His 6 -PsrA used in each reaction was 1 mg. To help solubilize FAs, especially LCFAs, Brij-58 was added at 0.01 % to all tubes. Lanes 3 and 4 for each gel are without and with 0.01 % Brij-58, respectively; as observed, there was no effect on the binding of PsrA to P fadBA5 DNA in the presence of this non-ionic detergent. All pictures are negative images of polyacrylamide gels stained with SYBR Green.
Conversely, PsrA positively activates several genes. Table 3 shows the list of genes potentially activated by PsrA, directly or indirectly. The majority of the genes regulated by PsrA are unknown hypothetical proteins, the future characterization of which will be interesting. One fadE homologue, PA2815, seems to be positively regulated by PsrA. Several genes involved in the production of type IV pili were expressed, and seem to be activated by PsrA. It is curious that the stationary-phase sigma factors rpoS and exsC of the type III secretion system, shown elsewhere to be positively regulated by PsrA (Kojic et al., 2002; Shen et al., 2006) , were not present in Table 3 . However, our GeneChip data are only representative of a single point during exponential growth, and the regulation of these two genes could occur later in the growth phases or be less than the twofold cut-off for our growth conditions.
Conclusions
Our laboratory has been interested in Fad of P. aeruginosa with respect to the lung environment (Son et al., 2007) . We have previously demonstrated the expression of genes in vivo in the lungs of CF patients, including fadBA5, which is required for PC and FA degradation in vitro (Son et al., 2007) . Cleavage of PC by P. aeruginosa phospholipases and subsequently by lipases (Martinez et al., 1999; Rosenau & Jaeger, 2000) will free the readily available LCFAs to the bacteria. These FAs are made mostly of C 16 : 0 (50-60 %) and~10-20 % of each of C 14 : 0 , C 16 : 1 , C 18 : 1 and C 18 : 2 (Postle et al., 1999) . These LCFAs would serve as inducers of Fad enzymes to metabolize LCFAs via b-oxidation. Indeed, the expression of psrA and fadBA5 has also been observed in vivo in the CF lung (Son et al., 2007) , suggesting that the bacteria sense free FAs in the lung for PsrA to derepress itself and fadBA5 to metabolize LCFAs.
We initiated this study to decipher the regulatory mechanism of the P. aeruginosa fadBA5 operon. FadBA5 was shown to be important for the utilization of LCFAs as sole carbon sources (Fig. 1) . We mapped the transcript start site and identified the promoter region of fadBA5 (Fig. 2) . The promoter region of fadBA5 was utilized to construct a P fadBA5 -lacZ chromosomal fusion, allowing us to demonstrate the regulation of fadBA5 by LCFAs in P. aeruginosa (Fig. 3) . The PAO1-P fadBA5 -lacZ fusion strain was used in transposon mutagenesis to identify a regulator for fadBA5, which is PsrA (PA3006). The DNA recognition sequence for PsrA binding is well established (Kojic et al., 2005; Shen et al., 2006) . Downstream of the fadBA5 promoter region, there were two putative PsrA binding sites (Figs 2a and 7) . Our EMSA confirmed this, and indicated that PsrA binds to P fadBA5 in vitro and that this binding is inhibited by LCFAs and not by long-chain acylCoAs (Fig. 6) . FadR, which regulates fad genes in E. coli, has been shown to bind to acyl-CoAs of ¢C12 to derepress Fad (DiRusso et al., 1992; Henry & Cronan, 1992) . This represents an interesting and novel difference between P. aeruginosa and E. coli LCFA degradation. Whether free FAs get into the cytoplasm to bind PsrA, or whether PsrA interacts closely with the membrane or other membrane proteins to obtain free FAs from the membrane, is a current enigma. Thus, how PsrA gains access to free FAs will be an interesting subject for future investigations. We further showed that PsrA is a global regulator of several genes, both positively and negatively. Among the genes repressed by PsrA were the ones leading to LCFA degradation, including fadBA5 and lipA, and this was confirmed by real-time RT-PCR. Finally, although PsrA seems to regulate some virulence genes (lipA and type IV pili genes), we focused on fadBA5 and propose here that PsrA is a b-oxidation regulator responding to LCFAs. It is exciting to anticipate the full physiological role of PsrA, once the functions of the many hypothetical proteins that it regulates are determined. 
